Concourse Financial Group Securities’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q2 | – | Hold |
0
| – | – | – | 10479 |
|
2023
Q1 | – | Hold |
0
| – | – | – | 10106 |
|
2022
Q4 | – | Hold |
0
| – | – | – | 10114 |
|
2022
Q3 | – | Hold |
0
| – | – | – | 9924 |
|
2022
Q2 | – | Hold |
0
| – | – | – | 9715 |
|
2022
Q1 | – | Hold |
0
| – | – | – | 9479 |
|
2021
Q4 | – | Hold |
0
| – | – | – | 9075 |
|
2021
Q3 | – | Hold |
0
| – | – | – | 8481 |
|
2021
Q2 | – | Hold |
0
| – | – | – | 8011 |
|
2021
Q1 | – | Hold |
0
| – | – | – | 7600 |
|